Treatment of postpartum thrombotic microangiopathy with plasma exchange using cryosupernatant as replacement

References

• Weiner CP. Thrombotic microangiopathy in pregnancy and the post-partum period. Semin Hematol 1987; 24: 119–29.
   PubMed Web of Science ®Google Scholar
• Ferris TF. Preeclampsia and postpartum renal failure: examples of pregnancy-induced microangiopathy. Am J Obstet Gynecol 1995; 99: 343–7.
   Google Scholar
• Coates PTH, Patrick G, Seymour A, Pugsley DJ, Hague W, Disney APS et al. Plasmapheresis in postpartum hemolytic uremic syndrome. Kidney Int 1997; 51: 1317.
   Google Scholar
• Sibai BM, Kustermann L, Velasco J. Current understanding of severe preeclampsia, pregnancy-associated hemolytic uremic syndrome, thrombotic thrombocytopenic purpura, hemolysis, elevated liver enzymes, and low platelet syndrome, and postpartum acute renal failure: different clinical syndromes or just different names? Curr Opin Nephrol Hypertens 1994; 3: 436–45.
   Google Scholar
• Egerman RS, Witlin AG, Friedman SA, Steven A, Sibai BM. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in pregnancy. Review of 11 cases. Am J Obstet Gynecol 1996; 175: 950–6.
   Google Scholar
• Ruggenenti P & Remuzzi G. Pathophysiology and management of thrombotic microangiopathies. J Nephrol 1998; 11: 300–10.
   Google Scholar
• George JN. How I treat patients with thrombotic thrombocytopenic purpura–hemolytic uremic syndrome. Blood 2000; 96: 1223–9.
   PubMed Web of Science ®Google Scholar
• Remuzzi G & Ruggenenti P. The hemolytic uremic syndrome. Kidney Int Suppl 1998; 53: S54–7.
   Google Scholar
• Neild GH. Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura. Pathophysiology and treatment. Kidney Int 1998; 53: 45–9.
   Google Scholar
• Förster JG, Peltonen S, Kaaja R, Lampinen K, Pettilä V. Plasma exchange in severe postpartum HELLP syndrome. Acta Anaesthesiol Scand 2002; 46: 955–8.
   PubMed Web of Science ®Google Scholar
• Dashe JS, Ramin SM, Cunningham FG. The long-term consequences of thrombotic microangiopathy (thrombotic thrombocytopenic purpura and hemolytic uremic syndrome) in pregnancy. Obstet Gynecol 1998; 91: 662–8.
   Google Scholar
• Harkness DR, Byrnes JJ, Lian EC-Y, Williams WD, Hensley GT. Hazard of platelet transfusion in thrombotic thrombocytopenic purpura. J Am Med Assoc 1981; 246: 1931–3.
   Google Scholar
• Ellis J, Theodossiu C, Schwarzenberger P. Treatment of thrombotic thrombocytopenic purpura with the cryosupernatant fraction of plasma: a case report and review of literature. Am J Med Sci 1999; 318: 190–6.
   Google Scholar
• Rock GA. Management of thrombotic thrombocytopenic purpura. Br J Haematol 2000; 109: 496–507.
   PubMed Web of Science ®Google Scholar
• Moake JL & McPherson PD. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic–uremic syndrome. Am J Med 1989; 87: 3N.
   PubMed Web of Science ®Google Scholar
• Moake JL, Byrnes JJ, Troll JH, Rudy CK, Weinstein MG, Colannina NM et al. Abnormal VIII: von Willebrand factor patterns in the plasma of patients with the hemolytic–uremic syndrome. Blood 1984; 64: 592–8.
   Google Scholar
• Kelton JG, Moore J, Santos A, Sheridan D. The detection of a platelet-agglutination factor in thrombotic thrombocytopenic purpura. Ann Intern Med 1984; 101: 589–93.
   Google Scholar
• Furlan M & Lämmle B. Hemolytic–uremic syndrome and thrombotic thrombocytopenic purpura – new insights into underlying biochemical mechanisms. Nephrol Dial Transplant 2000; 15: 1112–14.
   Google Scholar
• Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B et al. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998; 339: 1578–84.
   PubMed Web of Science ®Google Scholar
• Frangos JA, Moake JL, Nolasco L, Philips MD, McIntire LV. Cryosupernatant regulates accumulation of unusually large vWF multimers from endothelial cells. Am J Physiol 1989; 256: H1635–44.
   Google Scholar
• Rock G, Shumak KH, Sutton DM, David MC, Buskard NA, Nair RC. Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Br J Haematol 1996; 94: 383–6.
   PubMed Web of Science ®Google Scholar
• Byrnes JJ, Moake JL, Klug P, Periman P. Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura. Am J Hematol 1990; 34: 169–74.
   Web of Science ®Google Scholar